Sales rise 4.76% to Rs 34.57 crore
Net profit of Jenburkt Pharmaceuticals declined 12.84% to Rs 5.43 crore in the quarter ended December 2022 as against Rs 6.23 crore during the previous quarter ended December 2021. Sales rose 4.76% to Rs 34.57 crore in the quarter ended December 2022 as against Rs 33.00 crore during the previous quarter ended December 2021. ParticularsQuarter EndedDec. 2022Dec. 2021% Var.Sales34.5733.00 5 OPM %20.1621.12 -PBDT8.338.16 2 PBT7.757.69 1 NP5.436.23 -13Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
